Search Results
Ukraine’s Health Ministry and partners work on electronic procurement system The Ministry of Health of Ukraine signed a memorandum of understanding with the Eurasia Foundation (Transparency and Accountability in Public Administration and Services Program / TAPAS) on the implementation of the e-procurement development project. The project will open up opportunities for a large-scale development of the system for electronic procurement of medicines, medical devices, and other healthcare products in Ukraine, and will contribute to ensuring the professionalization of public procurement in the health sector.
Medicine procurement through international organizations: almost twice as many adult oncology patients get free medicines Every year, specialized international organizations that support Ukraine in procurement of medicines and healthcare products conduct transparent tenders and negotiate with manufacturers on prices, which results in savings of the allocated funds. The savings are used to purchase additional medicines to provide safe and effective treatment to more patients in need. The effective cooperation with international organizations in medicine procurement helped the Ukrainian government to provide free medicines to a significantly higher number of adult oncology patients. In 2016, the savings were used to purchase 90 out of all 94 centrally procured medicines.
A new shipment of 392,000 doses of MMR vaccine arrive to Ukraine At the request of the Ministry of Health of Ukraine and as part of support to the Government immunization program, the United Nations Children's Fund (UNICEF) has procured 392,000 doses of Measles, Mumps, Rubella (MMR) vaccine for Ukraine to respond to the continuing measles outbreak in the country. In total, over one million doses of MMR vaccine are currently available in Ukraine.
Ukraine purchases life-saving medicine for children with primary immunodeficiency diseases The Ministry of Health of Ukraine has purchased Anakinra – the life-saving medicine for the treatment of primary immunodeficiency in children. Before, this medicine was unavailable in Ukraine and parents of pediatric patients had to buy it at their own expense from abroad. The demand was relatively low, and the manufacturer was not interested in placing this medicine on the Ukrainian market.